- Home
- TEF vs WAT Comparison
TEF vs WAT Comparison
Compare TEF & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEF
- WAT
- Stock Information
- Founded
- TEF 1924
- WAT 1958
- Country
- TEF Spain
- WAT United States
- Employees
- TEF N/A
- WAT N/A
- Industry
- TEF Telecommunications Equipment
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- TEF Telecommunications
- WAT Industrials
- Exchange
- TEF Nasdaq
- WAT Nasdaq
- Market Cap
- TEF 29.9B
- WAT 20.8B
- IPO Year
- TEF 1987
- WAT 1995
- Fundamental
- Price
- TEF $5.18
- WAT $289.69
- Analyst Decision
- TEF
- WAT Hold
- Analyst Count
- TEF 0
- WAT 15
- Target Price
- TEF N/A
- WAT $379.27
- AVG Volume (30 Days)
- TEF 528.0K
- WAT 696.1K
- Earning Date
- TEF 07-30-2025
- WAT 08-04-2025
- Dividend Yield
- TEF 4.56%
- WAT N/A
- EPS Growth
- TEF N/A
- WAT 8.23
- EPS
- TEF N/A
- WAT 11.02
- Revenue
- TEF $44,356,895,792.00
- WAT $2,983,253,000.00
- Revenue This Year
- TEF N/A
- WAT $6.11
- Revenue Next Year
- TEF $0.17
- WAT $6.44
- P/E Ratio
- TEF N/A
- WAT $26.15
- Revenue Growth
- TEF 0.72
- WAT 2.57
- 52 Week Low
- TEF $3.89
- WAT $287.62
- 52 Week High
- TEF $5.48
- WAT $423.56
- Technical
- Relative Strength Index (RSI)
- TEF 46.22
- WAT 23.06
- Support Level
- TEF $5.17
- WAT $343.83
- Resistance Level
- TEF $5.23
- WAT $360.00
- Average True Range (ATR)
- TEF 0.04
- WAT 12.04
- MACD
- TEF -0.02
- WAT -5.40
- Stochastic Oscillator
- TEF 18.42
- WAT 3.35
About TEF Telefonica SA
Telefonica operates mobile and fixed networks in Spain (where it is the incumbent operator), the UK, Germany, Brazil, and Latin American countries. The company derives more than 30% of its revenue from Spain, close to 20% from Germany, and 20% from Brazil. Its UK operations are held through a joint venture with Virgin Media. For several years Telefonica has been simplifying its corporate structure by selling noncore assets.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions.